News Release

Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for COVID-19

Peer-Reviewed Publication

JAMA Network

What The Study Did: The association between angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and the severity of illness and death in patients with hypertension hospitalized for COVID-19 is examined in this study.

Authors: Aiping Deng, of the Central Hospital of Wuhan in China, is the corresponding author.

To access the embargoed study:  Visit our For The Media website at this link 


Editor's Note: Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.


Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.